Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06084013 · ClinicalTrials.gov registry record
Use Of Indocyanine Green In Pancreas Surgery
A clinical trial of Pancreatic Carcinoma, sponsored by OHSU Knight Cancer Institute.
- Recruiting
- Registry status
- 55
- Enrollment target
- 1
- Study location
NCT06084013 is a study of Pancreatic Carcinoma that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 55 participants, below the 3,482-participant average among 18 other Pancreatic Carcinoma trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06084013, a study of Pancreatic Carcinoma, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.
- RECRUITING
- Registry status
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Oregon
- OHSU Knight Cancer Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2024-05-17 |
| Est. Completion | 2026-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06084013
The ClinicalTrials.gov registry entry for NCT06084013 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,482-participant average among 18 other Pancreatic Carcinoma trials with a reported enrollment target (98% lower). The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06084013 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT06084013 about?
NCT06084013 is a clinical study titled "Use Of Indocyanine Green In Pancreas Surgery". This study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.
What is the current status of trial NCT06084013?
This trial is currently recruiting. The enrollment target is 55 participants. The study started on 2024-05-17. Estimated completion is 2026-02-28.
What conditions does trial NCT06084013 study?
This clinical trial studies the following conditions: Pancreatic Carcinoma.
What interventions are being tested in trial NCT06084013?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06084013?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06084013 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
RECRUITING · Phase 3
-
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
RECRUITING
-
Pilot Study of Pancreatic Cancer Screening
RECRUITING
-
A Study of MGC028 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Pancreatic Cancer Detection Consortium
RECRUITING
-
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.